The mechanism of TLR4 / NF-κB in atherosclerosis

doi:10. 3969 / j.issn.1671-7856. 2021. 04. 020

Home > Archive>Volume 31, Issue 4, 2021 >137-142. DOI:10. 3969 / j.issn.1671-7856. 2021. 04. 020

The mechanism of TLR4 / NF-κB in atherosclerosis
DOI:
                        10. 3969 / j.issn.1671-7856. 2021. 04. 020
                    
CSTR:
                        
Author:
                        
Affiliation:1.Department of Immunology, Basic Medical College of Guangxi Medical University, Nanning 530000, China. 2.Guangxi University of Chinese Medicine, Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Nanning 530200. 3.Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021
Clc Number:R-33
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Atherosclerosis (AS) is a chronic disease characterized by lipid deposits in blood vessels. An increasing number of studies suggest that immune-mediated inflammatory responses play an important role in the pathogenesis of AS. Toll-like receptor 4 (TLR4) participates in various stages of AS as a member of the natural immune pattern recognition receptor family, and thus has become an important target for the treatment of AS. This article reviews the progress in research regarding TLR4 and AS.

Reference

Cited by

Get Citation

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:November 09,2020
Revised:
Adopted:
Online: May 28,2021
Published:

Home

About

Editorial Board

Guidelines

Publishing Policy

Subscription

Contact Us

中文版

Get Citation

Related Videos

Share

Article Metrics

History

Article QR Code